SecBot SecBot
SECBOTREPLAY Home › Report › ARTV

ARTV · RA Capital Management, a 10% owner and director, made a series of…

Artiva Biotherapeutics, Inc. · INSIDER-BUY filed Jul 28, 2026 at 17:24 ET

At the news

BULLISHIMPACT 6/10

INSIDER-BUY filed Jul 28, 2026 at 17:24 ET

RA Capital Management, a 10% owner and director, made a series of open-market purchases totaling ~$3.07M over 7 days (July 17–24), with the bulk at $9.55–$9.99 per share. This is a conviction buy from a sophisticated healthcare investor, representing ~1.2% of ARTV's $255M market cap, and follows a prior cluster of $1.0M in RA Capital buys on July 23–24.

  • RA Capital Management (Director, 10% Owner) purchased ~313.8K shares total across 5 trades from July 17–24, 2026
  • Total purchase value: ~$3.07M, representing ~1.2% of ARTV's $255M market cap
  • Weighted average purchase price: ~$9.78 per share
  • Prior 30-day insider activity: 9 buys totaling $4.7M, indicating sustained insider accumulation

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access